Cubist Systematic Strategies’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Sell |
69,908
-85,614
| -55% | -$386K | ﹤0.01% | 1142 |
|
|
2025
Q1 | $689K | Buy |
155,522
+107,511
| +224% | +$476K | ﹤0.01% | 969 |
|
|
2024
Q4 | $376K | Buy |
+48,011
| New | +$376K | ﹤0.01% | 1051 |
|
|
2024
Q3 | – | Sell |
-6,597
| Closed | -$79.7K | – | 2348 |
|
|
2024
Q2 | $79.7K | Sell |
6,597
-71,189
| -92% | -$860K | ﹤0.01% | 1196 |
|
|
2024
Q1 | $1.26M | Buy |
77,786
+40,674
| +110% | +$661K | 0.01% | 1046 |
|
|
2023
Q4 | $253K | Buy |
37,112
+559
| +2% | +$3.81K | ﹤0.01% | 1563 |
|
|
2023
Q3 | $199K | Sell |
36,553
-101,995
| -74% | -$556K | ﹤0.01% | 1524 |
|
|
2023
Q2 | $941K | Buy |
138,548
+81,523
| +143% | +$554K | 0.01% | 1184 |
|
|
2023
Q1 | $286K | Buy |
57,025
+17,866
| +46% | +$89.5K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $191K | Buy |
39,159
+29,159
| +292% | +$142K | ﹤0.01% | 2663 |
|
|
2022
Q3 | $144K | Sell |
10,000
-542
| -5% | -$7.81K | ﹤0.01% | 3107 |
|
|
2022
Q2 | $160K | Sell |
10,542
-2,241
| -18% | -$34K | ﹤0.01% | 3254 |
|
|
2022
Q1 | $152K | Buy |
+12,783
| New | +$152K | ﹤0.01% | 3101 |
|
|
2021
Q4 | – | Sell |
-14,884
| Closed | -$425K | – | 3666 |
|
|
2021
Q3 | $425K | Buy |
+14,884
| New | +$425K | 0.01% | 2144 |
|
|
2021
Q1 | – | Sell |
-5,356
| Closed | -$265K | – | 2997 |
|
|
2020
Q4 | $265K | Buy |
+5,356
| New | +$265K | ﹤0.01% | 2101 |
|
|
2019
Q3 | – | Sell |
-520
| Closed | -$12K | – | 2523 |
|
|
2019
Q2 | $12K | Buy |
+520
| New | +$12K | ﹤0.01% | 2400 |
|
|
2018
Q4 | – | Sell |
-2,082
| Closed | -$55K | – | 2291 |
|
|
2018
Q3 | $55K | Buy |
+2,082
| New | +$55K | ﹤0.01% | 1678 |
|